Synopsis
0
USDMF
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
ABOUT THIS PAGE
31
PharmaCompass offers a list of Delta-Aminolevulinic Acid Methyl Ester API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Delta-Aminolevulinic Acid Methyl Ester manufacturer or Delta-Aminolevulinic Acid Methyl Ester supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Delta-Aminolevulinic Acid Methyl Ester manufacturer or Delta-Aminolevulinic Acid Methyl Ester supplier.
PharmaCompass also assists you with knowing the Delta-Aminolevulinic Acid Methyl Ester API Price utilized in the formulation of products. Delta-Aminolevulinic Acid Methyl Ester API Price is not always fixed or binding as the Delta-Aminolevulinic Acid Methyl Ester Price is obtained through a variety of data sources. The Delta-Aminolevulinic Acid Methyl Ester Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Metvixia manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Metvixia, including repackagers and relabelers. The FDA regulates Metvixia manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Metvixia API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Metvixia supplier is an individual or a company that provides Metvixia active pharmaceutical ingredient (API) or Metvixia finished formulations upon request. The Metvixia suppliers may include Metvixia API manufacturers, exporters, distributors and traders.
click here to find a list of Metvixia suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Metvixia CEP of the European Pharmacopoeia monograph is often referred to as a Metvixia Certificate of Suitability (COS). The purpose of a Metvixia CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Metvixia EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Metvixia to their clients by showing that a Metvixia CEP has been issued for it. The manufacturer submits a Metvixia CEP (COS) as part of the market authorization procedure, and it takes on the role of a Metvixia CEP holder for the record. Additionally, the data presented in the Metvixia CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Metvixia DMF.
A Metvixia CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Metvixia CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Metvixia suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Metvixia as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Metvixia API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Metvixia as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Metvixia and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Metvixia NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Metvixia suppliers with NDC on PharmaCompass.
Metvixia Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Metvixia GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Metvixia GMP manufacturer or Metvixia GMP API supplier for your needs.
A Metvixia CoA (Certificate of Analysis) is a formal document that attests to Metvixia's compliance with Metvixia specifications and serves as a tool for batch-level quality control.
Metvixia CoA mostly includes findings from lab analyses of a specific batch. For each Metvixia CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Metvixia may be tested according to a variety of international standards, such as European Pharmacopoeia (Metvixia EP), Metvixia JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Metvixia USP).
